Search Results

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc . (“Bioness”), a global leader in neuromodulation and rehabilitation medical devices through its innovative peripheral nerve stimulation (“PNS”) therapy and premium rehabilitation solutions, for $45 million in up-front consideration, with up to $65 million of contingent consideration

Bioness, Inc., the leading provider of cutting-edge, clinically supported rehabilitation therapies, today announced the commercial launch of the new Bioness Integrated Therapy System (BITS) for Balance.